151 related articles for article (PubMed ID: 14751568)
1. The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro.
Pan B; To LB; Farrugia AN; Findlay DM; Green J; Gronthos S; Evdokiou A; Lynch K; Atkins GJ; Zannettino AC
Bone; 2004 Jan; 34(1):112-23. PubMed ID: 14751568
[TBL] [Abstract][Full Text] [Related]
2. The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE).
Pan B; Farrugia AN; To LB; Findlay DM; Green J; Lynch K; Zannettino AC
J Bone Miner Res; 2004 Jan; 19(1):147-54. PubMed ID: 14753746
[TBL] [Abstract][Full Text] [Related]
3. Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition.
Chaplet M; Detry C; Deroanne C; Fisher LW; Castronovo V; Bellahcéne A
Biochem J; 2004 Dec; 384(Pt 3):591-8. PubMed ID: 15324309
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells.
Ubellacker JM; Haider MT; DeCristo MJ; Allocca G; Brown NJ; Silver DP; Holen I; McAllister SS
Breast Cancer Res; 2017 Mar; 19(1):23. PubMed ID: 28264701
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates modulate vital functions of human osteoblasts and affect their interactions with breast cancer cells.
Kaiser T; Teufel I; Geiger K; Vater Y; Aicher WK; Klein G; Fehm T
Breast Cancer Res Treat; 2013 Jul; 140(1):35-48. PubMed ID: 23807419
[TBL] [Abstract][Full Text] [Related]
6. Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating.
Greiner S; Kadow-Romacker A; Schmidmaier G; Wildemann B
J Biomed Mater Res A; 2009 Oct; 91(1):288-95. PubMed ID: 18980195
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.
Reinholz GG; Getz B; Pederson L; Sanders ES; Subramaniam M; Ingle JN; Spelsberg TC
Cancer Res; 2000 Nov; 60(21):6001-7. PubMed ID: 11085520
[TBL] [Abstract][Full Text] [Related]
8. Suppressive effects of N-bisphosphonate in osteoblastic cells mitigated by non-N-bisphosphonate but not by sodium-dependent phosphate cotransporter inhibitor.
Baba TT; Miyazaki T; Ohara-Nemoto Y; Nemoto TK
Cell Biochem Funct; 2019 Aug; 37(6):400-407. PubMed ID: 31328801
[TBL] [Abstract][Full Text] [Related]
9. Nitrogen Containing Bisphosphonates Impair the Release of Bone Homeostasis Mediators and Matrix Production by Human Primary Pre-Osteoblasts.
Giannasi C; Niada S; Farronato D; Lombardi G; Manfredi B; Farronato G; Brini AT
Int J Med Sci; 2019; 16(1):23-32. PubMed ID: 30662325
[TBL] [Abstract][Full Text] [Related]
10. Effect of β-tricalcium phosphate coated with zoledronic acid on human osteoblasts and human osteoclasts in vitro.
Kadow-Romacker A; Greiner S; Schmidmaier G; Wildemann B
J Biomater Appl; 2013 Jan; 27(5):577-85. PubMed ID: 21862509
[TBL] [Abstract][Full Text] [Related]
11. RAS-blocking bisphosphonate zoledronic acid inhibits the abnormal proliferation and differentiation of juvenile myelomonocytic leukemia cells in vitro.
Ohtsuka Y; Manabe A; Kawasaki H; Hasegawa D; Zaike Y; Watanabe S; Tanizawa T; Nakahata T; Tsuji K
Blood; 2005 Nov; 106(9):3134-41. PubMed ID: 16046524
[TBL] [Abstract][Full Text] [Related]
12. The effect of zoledronic acid incorporated in a poly(D,L-lactide) implant coating on osteoblasts in vitro.
Greiner S; Kadow-Romacker A; Lübberstedt M; Schmidmaier G; Wildemann B
J Biomed Mater Res A; 2007 Mar; 80(4):769-75. PubMed ID: 17041912
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.
Viereck V; Emons G; Lauck V; Frosch KH; Blaschke S; Gründker C; Hofbauer LC
Biochem Biophys Res Commun; 2002 Mar; 291(3):680-6. PubMed ID: 11855844
[TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid - a multiplicity of anti-cancer action.
Yuasa T; Kimura S; Ashihara E; Habuchi T; Maekawa T
Curr Med Chem; 2007; 14(20):2126-35. PubMed ID: 17691952
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate Modulation of the Gene Expression of Different Markers Involved in Osteoblast Physiology: Possible Implications in Bisphosphonate-Related Osteonecrosis of the Jaw.
Manzano-Moreno FJ; Ramos-Torrecillas J; Melguizo-Rodríguez L; Illescas-Montes R; Ruiz C; García-Martínez O
Int J Med Sci; 2018; 15(4):359-367. PubMed ID: 29511371
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic property of zoledronic acid by inhibition of endothelial progenitor cell differentiation.
Yamada J; Tsuno NH; Kitayama J; Tsuchiya T; Yoneyama S; Asakage M; Okaji Y; Shuno Y; Nishikawa T; Tanaka J; Takahashi K; Nagawa H
J Surg Res; 2009 Jan; 151(1):115-20. PubMed ID: 18619615
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates hinder osteoblastic/osteoclastic differentiation in the maxillary sinus mucosa-derived stem cells.
Zhang J; Park J; Lee JW; Kwon YD; Kim EC
Clin Oral Investig; 2018 Jun; 22(5):1933-1943. PubMed ID: 29188452
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of osteoblast function in vitro by aminobisphosphonates.
Orriss IR; Key ML; Colston KW; Arnett TR
J Cell Biochem; 2009 Jan; 106(1):109-18. PubMed ID: 19003973
[TBL] [Abstract][Full Text] [Related]
19. Zoledronic acid, an aminobisphosphonate, modulates differentiation and maturation of human dendritic cells.
Chen YJ; Chao KS; Yang YC; Hsu ML; Lin CP; Chen YY
Immunopharmacol Immunotoxicol; 2009; 31(3):499-508. PubMed ID: 19555208
[TBL] [Abstract][Full Text] [Related]
20. Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis.
Evdokiou A; Labrinidis A; Bouralexis S; Hay S; Findlay DM
Bone; 2003 Aug; 33(2):216-28. PubMed ID: 14499355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
